WODC, the largest and most established industry event on rare diseases and orphan drugs in Europe, is dedicated to fostering partnerships between industry, governments, payers, investors and patients through patient support groups.

Regardless of whether your interest lies in research, clinical development, patient access, global pricing and reimbursement, or just to engage with patient advocacy groups more intimately, WODC Europe has content, networking and potential partners for you!

Join EHA and some 450+ of our colleagues make use of experts, from patient advocacy groups, non-profit and charity to government organisations, payers and pharma, under one roof – simply choose the sessions which are the most applicable to help your business plan for the future of orphan drug research, development and manufacture.

For more information, please visit the WODC Europe website or download the brochure here. Alternatively, register now.